Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2017 08:00 ET | Source: Depomed, Inc

Depomed to Present at Healthcare Conferences in March

NEWARK, Calif., March 06, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that senior management will present at the following healthcare conferences during the month of March. ...
February 21, 2017 16:01 ET | Source: Depomed, Inc

Depomed Reports Fourth Quarter and Full Year 2016 Financial Results

- Record Annual Revenue of $456 million in 2016 - - Record Quarterly Revenue of $124 million in Fourth Quarter – - Conference Call Scheduled for Today at 4:30 PM EST; Dial-In Information Below - ...
February 17, 2017 08:00 ET | Source: Depomed, Inc

Depomed to Report Fourth Quarter Fiscal Year 2016 Financial Results on Tuesday, February 21, 2017

NEWARK, Calif., Feb. 17, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release fourth quarter fiscal year 2016 financial results after the close of market,...
February 08, 2017 08:00 ET | Source: Depomed, Inc

Depomed to Present at Healthcare Conferences in February

NEWARK, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that members of senior management will participate in fireside chats at the following healthcare...
November 22, 2016 16:01 ET | Source: Depomed, Inc

Depomed to Present at the Annual Piper Jaffray Healthcare Conference

NEWARK, Calif., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will participate in a fireside chat at the 28th Annual Piper Jaffray Healthcare Conference...
November 16, 2016 08:00 ET | Source: Depomed, Inc

Depomed Named to Deloitte's Technology Fast 500™ List of Fastest Growing Companies in North America

NEWARK, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO), a leading pharmaceutical company focused on central nervous system conditions including pain, today announced that it...
November 07, 2016 16:00 ET | Source: Depomed, Inc

Depomed Reports Third Quarter 2016 Financial Results

- Third Quarter Revenues of $111 million - - Conference Call Scheduled for Today at 4:30 PM EST; Dial-In Information Below - NEWARK, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc....
November 04, 2016 08:00 ET | Source: Depomed, Inc

Depomed Announces New CAMBIA® Formulation

NEWARK, Calif., Nov. 04, 2016 (GLOBE NEWSWIRE) -- Depomed Inc. (NASDAQ:DEPO) today announced the introduction of a new formulation of CAMBIA® (diclofenac potassium) for oral solution, that...
October 31, 2016 16:00 ET | Source: Depomed, Inc

Depomed to Report Third Quarter Fiscal Year 2016 Financial Results on Monday, November 7, 2016

NEWARK, Calif., Oct. 31, 2016 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release third quarter fiscal year 2016 financial results after the close of market,...
October 17, 2016 16:00 ET | Source: Depomed, Inc

Depomed and Starboard Announce Settlement Agreement

- Depomed Board to Include Three New Independent Directors - - Starboard to Withdraw Request for Special Meeting - NEWARK, Calif., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Depomed Inc. (NASDAQ:DEPO)...